Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid

Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid Pfizer Inc said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA). Reuters Reuters

...

Pfizer said it submitted a New Drug Application for Paxlovid to the Food and Drug Administration for the treatment of COVID-19 in vaccinated and unvaccinated people at high risk for progression to severe illness. 

...